Man Group PLC Amgen Inc Transaction History

Man Group PLC

$36 Billion
Q3 2024

A detailed history of Man Group PLC transactions in Amgen Inc stock. As of the latest transaction made, Man Group PLC holds 275,260 shares of AMGN stock, worth $81.1 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

275,260

Previous 228,128 20.66%

Holding current value

$81.1 Million

Previous $71.3 Million 24.43%

% of portfolio

0.25%

Previous 0.19%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $14.6 Million - $15.9 Million	47,132 Added 20.66%	275,260 $88.7 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $36.2 Million - $44 Million	-137,746 Reduced 37.65%	228,128 $71.3 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $60.4 Million - $72.9 Million	224,465 Added 158.73%	365,874 $104 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $6.31 Million - $7.12 Million	24,682 Added 21.15%	141,409 $40.7 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $6.36 Million - $7.89 Million	-29,066 Reduced 19.94%	116,727 $31.4 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $11 Million - $13 Million	51,452 Added 54.54%	145,793 $32.4 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $19.9 Million - $24.3 Million	-88,227 Reduced 48.33%	94,341 $22.8 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $8.71 Million - $11.1 Million	38,010 Added 26.29%	182,568 $47.9 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $9.14 Million - $10.3 Million	40,742 Added 39.24%	144,558 $32.6 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $15.2 Million - $16.9 Million	-65,840 Reduced 38.81%	103,816 $25.3 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $26.7 Million - $29.5 Million	-121,788 Reduced 41.79%	169,656 $41 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $38.7 Million - $44.3 Million	194,585 Added 200.9%	291,444 $65.6 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $11.5 Million - $13.5 Million	-54,109 Reduced 35.84%	96,859 $20.6 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $8.72 Million - $9.68 Million	37,351 Added 32.87%	150,968 $36.8 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $24.4 Million - $28.5 Million	-110,070 Reduced 49.21%	113,617 $28.3 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $25.5 Million - $30.4 Million	-118,069 Reduced 34.55%	223,687 $51.4 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $50.3 Million - $55.9 Million	-214,310 Reduced 38.54%	341,756 $86.9 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $49.9 Million - $61.2 Million	252,024 Added 82.89%	556,066 $131 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $73 Million - $96.8 Million	-400,642 Reduced 56.85%	304,042 $61.6 Million
Q4 2019 Feb 18, 2020	SELL	$189.21 - $243.2 $71.4 Million - $91.8 Million	-377,306 Reduced 34.87%	704,684 $170 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $40.6 Million - $48.6 Million	233,160 Added 27.47%	1,081,990 $209 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $35.6 Million - $41.7 Million	213,259 Added 33.55%	848,830 $156 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $34.5 Million - $38.9 Million	-190,644 Reduced 23.07%	635,571 $121 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $62.4 Million - $72.8 Million	-349,809 Reduced 29.75%	826,215 $161 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $10.7 Million - $12 Million	-57,634 Reduced 4.67%	1,176,024 $244 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $44.9 Million - $50.4 Million	270,469 Added 28.08%	1,233,658 $228 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $163 Million - $191 Million	963,189 New	963,189 $164 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account